The 2022 Women’s Health Policy Agenda outlines policy priorities across five key areas—public health, research and clinical trials, lifespan issues, coverage and access, and the biomedical research workforce.
SWHR hosts a series of public forums to share educational information about the importance and value of innovative diagnostics throughout the lifespan and across disease states and conditions. This event discusses how to improve health outcomes for diseases and conditions that disproportionately affect women, with a focus on bone health.
SWHR convened an interdisciplinary Bone Health Working Group of health care providers, researchers, patient advocates, and policy leaders for a closed, roundtable meeting in April 2022. During the roundtable, the Working Group discussed scientific and policy issues in women’s bone health, including strategies for fracture prevention in at-risk women.
More than 8 million people in the United States are living with psoriasis, a chronic immune-mediated condition where skin cells multiply 10 times faster than the normal rate.
Do endometriosis and uterine fibroids impact bone health? SWHR explores the connection between these gynecological conditions, estrogen, and healthy bones.
May is National Osteoporosis Month! About 80% of the approximate 10 million Americans with osteoporosis are women. A woman’s risk […]
Implementing broader efforts around the prevention of osteoporosis and treatment of related fractures would have a major impact on women’s quality of life.
SWHR published a review in the Journal of Women’s Health highlighting research gaps and unmet needs around sex and genders differences in osteoarthritis (OA) research, diagnosis, care, and education.
The Society for Women’s Health Research (SWHR) published a review in The Journal of Women’s Health assessing research gaps and […]